Literature DB >> 33769947

Communicating Scientific Uncertainty About the COVID-19 Pandemic: Online Experimental Study of an Uncertainty-Normalizing Strategy.

Paul K J Han1, Elizabeth Scharnetzki1, Aaron M Scherer2, Alistair Thorpe3, Christine Lary1, Leo B Waterston1, Angela Fagerlin3,4, Nathan F Dieckmann5.   

Abstract

BACKGROUND: Communicating scientific uncertainty about public health threats such as COVID-19 is an ethically desirable task endorsed by expert guidelines on crisis communication. However, the communication of scientific uncertainty is challenging because of its potential to promote ambiguity aversion-a well-described syndrome of negative psychological responses consisting of heightened risk perceptions, emotional distress, and decision avoidance. Communication strategies that can inform the public about scientific uncertainty while mitigating ambiguity aversion are a critical unmet need.
OBJECTIVE: This study aimed to evaluate whether an "uncertainty-normalizing" communication strategy-aimed at reinforcing the expected nature of scientific uncertainty about the COVID-19 pandemic-can reduce ambiguity aversion, and to compare its effectiveness to conventional public communication strategies aimed at promoting hope and prosocial values.
METHODS: In an online factorial experiment conducted from May to June 2020, a national sample of 1497 US adults read one of five versions of an informational message describing the nature, transmission, prevention, and treatment of COVID-19; the versions varied in level of expressed scientific uncertainty and supplemental focus (ie, uncertainty-normalizing, hope-promoting, and prosocial). Participants then completed measures of cognitive, emotional, and behavioral manifestations of ambiguity aversion (ie, perceived likelihood of getting COVID-19, COVID-19 worry, and intentions for COVID-19 risk-reducing behaviors and vaccination). Analyses assessed (1) the extent to which communicating uncertainty produced ambiguity-averse psychological responses; (2) the comparative effectiveness of uncertainty-normalizing, hope-promoting, and prosocial communication strategies in reducing ambiguity-averse responses; and (3) potential moderators of the effects of alternative uncertainty communication strategies.
RESULTS: The communication of scientific uncertainty about the COVID-19 pandemic increased perceived likelihood of getting COVID-19 and worry about COVID-19, consistent with ambiguity aversion. However, it did not affect intentions for risk-reducing behaviors or vaccination. The uncertainty-normalizing strategy reduced these aversive effects of communicating scientific uncertainty, resulting in levels of both perceived likelihood of getting COVID-19 and worry about COVID-19 that did not differ from the control message that did not communicate uncertainty. In contrast, the hope-promoting and prosocial strategies did not decrease ambiguity-averse responses to scientific uncertainty. Age and political affiliation, respectively, moderated the effects of uncertainty communication strategies on intentions for COVID-19 risk-reducing behaviors and worry about COVID-19.
CONCLUSIONS: Communicating scientific uncertainty about the COVID-19 pandemic produces ambiguity-averse cognitive and emotional, but not behavioral, responses among the general public, and an uncertainty-normalizing communication strategy reduces these responses. Normalizing uncertainty may be an effective strategy for mitigating ambiguity aversion in crisis communication efforts. More research is needed to test uncertainty-normalizing communication strategies and to elucidate the factors that moderate their effectiveness. ©Paul K J Han, Elizabeth Scharnetzki, Aaron M Scherer, Alistair Thorpe, Christine Lary, Leo B Waterston, Angela Fagerlin, Nathan F Dieckmann. Originally published in the Journal of Medical Internet Research (https://www.jmir.org), 22.04.2021.

Entities:  

Keywords:  COVID-19; ambiguity; communication; uncertainty; vaccination

Year:  2021        PMID: 33769947     DOI: 10.2196/27832

Source DB:  PubMed          Journal:  J Med Internet Res        ISSN: 1438-8871            Impact factor:   5.428


  7 in total

1.  Fight Like a Nerdy Girl: The Dear Pandemic Playbook for Combating Health Misinformation.

Authors:  Lindsey J Leininger; Sandra S Albrecht; Alison Buttenheim; Jennifer Beam Dowd; Ashley Z Ritter; Amanda M Simanek; Mary-Jo Valentino; Malia Jones
Journal:  Am J Health Promot       Date:  2022-03

2.  Psychological Impact of Ambiguous Health Messages about COVID-19.

Authors:  Nicolle Simonovic; Jennifer M Taber
Journal:  J Behav Med       Date:  2021-11-23

3.  Knowing Well, Being Well: well-being born of understanding: The Urgent Need for Coordinated and Comprehensive Efforts to Combat Misinformation.

Authors:  Sara S Johnson
Journal:  Am J Health Promot       Date:  2022-03

4.  Perceptions and tolerance of uncertainty: relationship to trust in COVID-19 health information and vaccine hesitancy.

Authors:  Arielle S Gillman; Liz Scharnetzki; Patrick Boyd; Rebecca A Ferrer; William M P Klein; Paul K J Han
Journal:  J Behav Med       Date:  2022-04-08

5.  A comparative analysis of experienced uncertainties in relation to risk communication during COVID19: a four-country study.

Authors:  Florin Cristea; Heide Weishaar; Brogan Geurts; Alexandre Delamou; Melisa Mei Jin Tan; Helena Legido-Quigley; Kafayat Aminu; Almudena Mari-Sáez; Carlos Rocha; Bienvenu Camara; Lansana Barry; Paul Thea; Johannes Boucsein; Thurid Bahr; Sameh Al-Awlaqi; Francisco Pozo-Martin; Evgeniya Boklage; Ayodele Samuel Jegede; Charbel El Bcheraoui
Journal:  Global Health       Date:  2022-06-27       Impact factor: 10.401

6.  The Impact of Communicating Uncertainty on Public Responses to Precision Medicine Research.

Authors:  Chelsea L Ratcliff; Bob Wong; Jakob D Jensen; Kimberly A Kaphingst
Journal:  Ann Behav Med       Date:  2021-10-27

Review 7.  The Effectiveness of Interventions for Increasing COVID-19 Vaccine Uptake: A Systematic Review.

Authors:  Eleonore Batteux; Freya Mills; Leah Ffion Jones; Charles Symons; Dale Weston
Journal:  Vaccines (Basel)       Date:  2022-03-03
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.